Prophylactic Human Vaccines Market Report

China Prophylactic Human Vaccines Industry Market Research Report 2023-2029

  • POSTDATE：Oct 02, 2023
  • PAGES：197
  • REPORT CODE：GMM1819291
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Prophylactic Human Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Shanghai BravoBio Co, Ltd (China)

    • Bharat Biotech International Limited (India)

    • Altimmune, Inc (US)

    • Serum Institute of India Pvt Ltd (India)

    • MedImmune (US)

    • Hualan Biological Engineering Inc (China)

    • ALK - Abello A/S (Denmark)

    • Merck & Co, Inc (US)

    • Seqirus (UK)

    • GlaxoSmithKline Plc (UK)

    • Pfizer Inc (US)

    • Janssen Pharmaceuticals, Inc (US)

    • Bavarian Nordic A/S (Denmark)

    • BiondVax Pharmaceuticals Ltd (Israel)

    • Sanofi Pasteur SA (France)

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Prophylactic Human Vaccines Market Overview 2018-2029

    • 1.1 China Prophylactic Human Vaccines Industry Development Overview

    • 1.2 China Prophylactic Human Vaccines Industry Development History

    • 1.3 China Prophylactic Human Vaccines Industry Market Size (2018-2029)

    • 1.4 China Prophylactic Human Vaccines Market Analysis by Type from Production Side

      • 1.4.1 China Prophylactic Human Vaccines Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Prophylactic Human Vaccines Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Prophylactic Human Vaccines Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Prophylactic Human Vaccines Market Analysis by Application from Consumption End

      • 1.5.1 China Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Prophylactic Human Vaccines Market Analysis by Region

      • 1.6.1 North China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Prophylactic Human Vaccines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Prophylactic Human Vaccines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Prophylactic Human Vaccines Market Status and Competition Analysis in 2023

      • 2.2.3 China Prophylactic Human Vaccines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Prophylactic Human Vaccines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Prophylactic Human Vaccines Industry Development

    Chapter 3 Prophylactic Human VaccinesIndustry Chain Analysis

    • 3.1 Prophylactic Human Vaccines Industry Chain

    • 3.2 Prophylactic Human Vaccines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Prophylactic Human Vaccines Market

    • 3.3 Prophylactic Human Vaccines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Prophylactic Human Vaccines Market

    Chapter 4 China Prophylactic Human Vaccines Market, by Type

    • 4.1 China Prophylactic Human Vaccines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Prophylactic Human Vaccines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Prophylactic Human Vaccines Production Volume and Growth Rate, by Type

      • 4.5.1 China Prophylactic Human Vaccines Production Volume and Growth Rate of Type 1

      • 4.5.2 China Prophylactic Human Vaccines Production Volume and Growth Rate of Type 2

      • 4.5.3 China Prophylactic Human Vaccines Production Volume and Growth Rate of Type 3

    Chapter 5 China Prophylactic Human Vaccines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Prophylactic Human Vaccines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Prophylactic Human Vaccines Market Size and Growth Rate, by Application

      • 5.5.1 China Prophylactic Human Vaccines Market Size and Growth Rate of Application 1

      • 5.5.2 China Prophylactic Human Vaccines Market Size and Growth Rate of Application 2

      • 5.5.3 China Prophylactic Human Vaccines Market Size and Growth Rate of Application 3

    Chapter 6 China Prophylactic Human Vaccines Market, by Region

    • 6.1 China Prophylactic Human Vaccines Production Volume and Production Value, by Region

    • 6.2 China Prophylactic Human Vaccines Sales Volume and Sales Value, by Region

    Chapter 7 North China Prophylactic Human Vaccines Market Analysis

    • 7.1 North China Prophylactic Human Vaccines Market, by Type

    • 7.2 North China Prophylactic Human Vaccines Market, by Application

    Chapter 8 Central China Prophylactic Human Vaccines Market Analysis

    • 8.1 Central China Prophylactic Human Vaccines Market, by Type

    • 8.2 Central China Prophylactic Human Vaccines Market, by Application

    Chapter 9 South China Prophylactic Human Vaccines Market Analysis

    • 9.1 South China Prophylactic Human Vaccines Market, by Type

    • 9.2 South China Prophylactic Human Vaccines Market, by Application

    Chapter 10 East China Prophylactic Human Vaccines Market Analysis

    • 10.1 East China Prophylactic Human Vaccines Market, by Type

    • 10.2 East China Prophylactic Human Vaccines Market, by Application

    Chapter 11 Northeast China Prophylactic Human Vaccines Market Analysis

    • 11.1 Northeast China Prophylactic Human Vaccines Market, by Type

    • 11.2 Northeast China Prophylactic Human Vaccines Market, by Application

    Chapter 12 Southwest China Prophylactic Human Vaccines Market Analysis

    • 12.1 Southwest China Prophylactic Human Vaccines Market, by Type

    • 12.2 Southwest China Prophylactic Human Vaccines Market, by Application

    Chapter 13 Northwest China Prophylactic Human Vaccines Market Analysis

    • 13.1 Northwest China Prophylactic Human Vaccines Market, by Type

    • 13.2 Northwest China Prophylactic Human Vaccines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Shanghai BravoBio Co, Ltd (China)

        • 14.1.1 Shanghai BravoBio Co, Ltd (China) Company Profile

        • 14.1.2 Shanghai BravoBio Co, Ltd (China) Prophylactic Human Vaccines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bharat Biotech International Limited (India)

        • 14.2.1 Bharat Biotech International Limited (India) Company Profile

        • 14.2.2 Bharat Biotech International Limited (India) Prophylactic Human Vaccines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Altimmune, Inc (US)

        • 14.3.1 Altimmune, Inc (US) Company Profile

        • 14.3.2 Altimmune, Inc (US) Prophylactic Human Vaccines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Serum Institute of India Pvt Ltd (India)

        • 14.4.1 Serum Institute of India Pvt Ltd (India) Company Profile

        • 14.4.2 Serum Institute of India Pvt Ltd (India) Prophylactic Human Vaccines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 MedImmune (US)

        • 14.5.1 MedImmune (US) Company Profile

        • 14.5.2 MedImmune (US) Prophylactic Human Vaccines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Hualan Biological Engineering Inc (China)

        • 14.6.1 Hualan Biological Engineering Inc (China) Company Profile

        • 14.6.2 Hualan Biological Engineering Inc (China) Prophylactic Human Vaccines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 ALK - Abello A/S (Denmark)

        • 14.7.1 ALK - Abello A/S (Denmark) Company Profile

        • 14.7.2 ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Merck & Co, Inc (US)

        • 14.8.1 Merck & Co, Inc (US) Company Profile

        • 14.8.2 Merck & Co, Inc (US) Prophylactic Human Vaccines Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Seqirus (UK)

        • 14.9.1 Seqirus (UK) Company Profile

        • 14.9.2 Seqirus (UK) Prophylactic Human Vaccines Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 GlaxoSmithKline Plc (UK)

        • 14.10.1 GlaxoSmithKline Plc (UK) Company Profile

        • 14.10.2 GlaxoSmithKline Plc (UK) Prophylactic Human Vaccines Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Pfizer Inc (US)

        • 14.11.1 Pfizer Inc (US) Company Profile

        • 14.11.2 Pfizer Inc (US) Prophylactic Human Vaccines Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Janssen Pharmaceuticals, Inc (US)

        • 14.12.1 Janssen Pharmaceuticals, Inc (US) Company Profile

        • 14.12.2 Janssen Pharmaceuticals, Inc (US) Prophylactic Human Vaccines Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Bavarian Nordic A/S (Denmark)

        • 14.13.1 Bavarian Nordic A/S (Denmark) Company Profile

        • 14.13.2 Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 BiondVax Pharmaceuticals Ltd (Israel)

        • 14.14.1 BiondVax Pharmaceuticals Ltd (Israel) Company Profile

        • 14.14.2 BiondVax Pharmaceuticals Ltd (Israel) Prophylactic Human Vaccines Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Sanofi Pasteur SA (France)

        • 14.15.1 Sanofi Pasteur SA (France) Company Profile

        • 14.15.2 Sanofi Pasteur SA (France) Prophylactic Human Vaccines Market Performance

        • 14.15.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Prophylactic Human Vaccines Industry Research Conclusions

    • 15.2 Prophylactic Human Vaccines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Prophylactic Human Vaccines Industry Market Size (2018-2029)

    • Figure China Prophylactic Human Vaccines Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Prophylactic Human Vaccines Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Prophylactic Human Vaccines Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Prophylactic Human Vaccines Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Central China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

    • Figure South China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

    • Figure East China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Prophylactic Human Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Prophylactic Human Vaccines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Prophylactic Human Vaccines Market Share by Type in 2018

    • Figure China Prophylactic Human Vaccines Market Share by Type in 2023

    • Figure China Prophylactic Human Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Prophylactic Human Vaccines Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Prophylactic Human Vaccines Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Prophylactic Human Vaccines Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Prophylactic Human Vaccines Market Share by Application in 2018

    • Figure China Prophylactic Human Vaccines Market Share by Application in 2023

    • Figure China Prophylactic Human Vaccines Total Market Size and Growth Rate from Consumption End

    • Figure China Prophylactic Human Vaccines Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Prophylactic Human Vaccines Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Prophylactic Human Vaccines Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Prophylactic Human Vaccines Production Volume by Region (2018-2023)

    • Table China Prophylactic Human Vaccines Production Volume Share by Region (2018-2023)

    • Figure China Prophylactic Human Vaccines Production Volume Share by Region (2018-2023)

    • Table China Prophylactic Human Vaccines Production Value by Region (2018-2023)

    • Table China Prophylactic Human Vaccines Production Value Share by Region (2018-2023)

    • Figure China Prophylactic Human Vaccines Production Value Share by Region (2018-2023)

    • Table China Prophylactic Human Vaccines Sales Volume by Region (2018-2023)

    • Table China Prophylactic Human Vaccines Sales Volume Share by Region (2018-2023)

    • Figure China Prophylactic Human Vaccines Sales Volume Share by Region (2018-2023)

    • Table China Prophylactic Human Vaccines Sales Value by Region (2018-2023)

    • Table China Prophylactic Human Vaccines Sales Value Share by Region (2018-2023)

    • Figure China Prophylactic Human Vaccines Sales Value Share by Region (2018-2023)

    • Table North China Prophylactic Human Vaccines Production Volume by Type (2018-2023)

    • Table North China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Figure North China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Table North China Prophylactic Human Vaccines Sales Volume by Application (2018-2023)

    • Table North China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Figure North China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Table Central China Prophylactic Human Vaccines Production Volume by Type (2018-2023)

    • Table Central China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Figure Central China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Table Central China Prophylactic Human Vaccines Sales Volume by Application (2018-2023)

    • Table Central China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Central China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Table South China Prophylactic Human Vaccines Production Volume by Type (2018-2023)

    • Table South China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Figure South China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Table South China Prophylactic Human Vaccines Sales Volume by Application (2018-2023)

    • Table South China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Figure South China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Table East China Prophylactic Human Vaccines Production Volume by Type (2018-2023)

    • Table East China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Figure East China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Table East China Prophylactic Human Vaccines Sales Volume by Application (2018-2023)

    • Table East China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Figure East China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Prophylactic Human Vaccines Production Volume by Type (2018-2023)

    • Table Northeast China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Table Northeast China Prophylactic Human Vaccines Sales Volume by Application (2018-2023)

    • Table Northeast China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Prophylactic Human Vaccines Production Volume by Type (2018-2023)

    • Table Southwest China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Table Southwest China Prophylactic Human Vaccines Sales Volume by Application (2018-2023)

    • Table Southwest China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Prophylactic Human Vaccines Production Volume by Type (2018-2023)

    • Table Northwest China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Prophylactic Human Vaccines Production Volume Share by Type (2018-2023)

    • Table Northwest China Prophylactic Human Vaccines Sales Volume by Application (2018-2023)

    • Table Northwest China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Prophylactic Human Vaccines Sales Volume Share by Application (2018-2023)

    • Table Shanghai BravoBio Co, Ltd (China) Company Profile

    • Table Shanghai BravoBio Co, Ltd (China) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table Bharat Biotech International Limited (India) Company Profile

    • Table Bharat Biotech International Limited (India) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table Altimmune, Inc (US) Company Profile

    • Table Altimmune, Inc (US) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table Serum Institute of India Pvt Ltd (India) Company Profile

    • Table Serum Institute of India Pvt Ltd (India) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table MedImmune (US) Company Profile

    • Table MedImmune (US) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table Hualan Biological Engineering Inc (China) Company Profile

    • Table Hualan Biological Engineering Inc (China) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table ALK - Abello A/S (Denmark) Company Profile

    • Table ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc (US) Company Profile

    • Table Merck & Co, Inc (US) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table Seqirus (UK) Company Profile

    • Table Seqirus (UK) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Plc (UK) Company Profile

    • Table GlaxoSmithKline Plc (UK) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc (US) Company Profile

    • Table Pfizer Inc (US) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table Janssen Pharmaceuticals, Inc (US) Company Profile

    • Table Janssen Pharmaceuticals, Inc (US) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table Bavarian Nordic A/S (Denmark) Company Profile

    • Table Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table BiondVax Pharmaceuticals Ltd (Israel) Company Profile

    • Table BiondVax Pharmaceuticals Ltd (Israel) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)

    • Table Sanofi Pasteur SA (France) Company Profile

    • Table Sanofi Pasteur SA (France) Prophylactic Human Vaccines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US